About icon - ICLR
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
ICLR At a Glance
ICON plc
South County Business Park
Dublin, Dublin 18
| Phone | 353-1-291-2000 | Revenue | 8.28B | |
| Industry | Miscellaneous Commercial Services | Net Income | 791.47M | |
| Sector | Commercial Services | 2024 Sales Growth | 1.989% | |
| Fiscal Year-end | 12 / 2025 | Employees | 41,900 | |
| View SEC Filings |
ICLR Valuation
| P/E Current | 19.656 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 22.00 |
| Price to Sales Ratio | 2.103 |
| Price to Book Ratio | 1.778 |
| Price to Cash Flow Ratio | 13.53 |
| Enterprise Value to EBITDA | 11.838 |
| Enterprise Value to Sales | 2.473 |
| Total Debt to Enterprise Value | 0.176 |
ICLR Efficiency
| Revenue/Employee | 197,653.365 |
| Income Per Employee | 18,889.594 |
| Receivables Turnover | 2.905 |
| Total Asset Turnover | 0.489 |
ICLR Liquidity
| Current Ratio | 1.263 |
| Quick Ratio | 1.263 |
| Cash Ratio | 0.193 |
ICLR Profitability
| Gross Margin | 23.52 |
| Operating Margin | 14.507 |
| Pretax Margin | 10.495 |
| Net Margin | 9.557 |
| Return on Assets | 4.674 |
| Return on Equity | 8.436 |
| Return on Total Capital | 6.03 |
| Return on Invested Capital | 6.067 |
ICLR Capital Structure
| Total Debt to Total Equity | 37.835 |
| Total Debt to Total Capital | 27.449 |
| Total Debt to Total Assets | 21.348 |
| Long-Term Debt to Equity | 37.136 |
| Long-Term Debt to Total Capital | 26.943 |